{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T06:11:42Z","timestamp":1778134302888,"version":"3.51.4"},"reference-count":17,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T00:00:00Z","timestamp":1769385600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Riken Genesis Co., Ltd., Tokyo, Japan"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Comprehensive biomarker testing is mandatory for advanced non-small cell lung cancer (NSCLC). Pleural effusion cell blocks are a minimally invasive alternative to biopsy. The AmoyDx pan lung cancer (PLC) polymerase chain reaction panel is a sensitive multiplex assay; however, its performance using pleural cell-block specimens with low tumor-cell content remains largely unexplored.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective study of 30 patients with advanced NSCLC and having known driver mutations, whose pleural effusion cell blocks were tested using the AmoyDx PLC panel at Kanagawa Cancer Center between 2021 and 2023. Tumor content was quantified using thyroid transcription factor 1 immunohistochemistry. DNA and RNA quality were assessed, and the panel results were compared with those of other molecular assays.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The AmoyDx PLC panel achieved a detection success rate of 96.7% (29\/30), with a sole discordant case owing to the absence of malignant cells. The concordance in confirmed malignant cases was 100%. Notably, the panel detected target mutations in specimens with tumor contents well below the recommended threshold. High detection performance was observed even when the nucleic acid concentrations were suboptimal or the purity levels were outside the reference range. The median tumor content was 8.5% (range, 0.2%\u201388.2%), with 74% samples below the 20% threshold.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Pleural effusion cell blocks are a practical and reliable alternative for molecular testing of advanced NSCLC when biopsy is not feasible. The high sensitivity of the AmoyDx PLC panel even for specimens with low tumor cell content underscores its potential clinical utility.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/jjco\/hyag003","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T12:42:57Z","timestamp":1767789777000},"page":"605-611","source":"Crossref","is-referenced-by-count":0,"title":["Utility of AMOY polymerase chain reaction panel in detecting non-small cell lung cancer using pleural cell block"],"prefix":"10.1093","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5104-5493","authenticated-orcid":false,"given":"Shuji","family":"Murakami","sequence":"first","affiliation":[{"name":"Department of Thoracic Oncology, Kanagawa Cancer Center , Kanagawa 241-8515 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanako","family":"Shinada","sequence":"additional","affiliation":[{"name":"Department of Thoracic Oncology, Kanagawa Cancer Center , Kanagawa 241-8515 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuka","family":"Otsuzumi","sequence":"additional","affiliation":[{"name":"Department of Pathology, Kanagawa Cancer Center, Kanagawa Cancer Center , Kanagawa 241-8515 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinya","family":"Sato","sequence":"additional","affiliation":[{"name":"Morphological Analysis Laboratory, Kanagawa Cancer Center Research Institute Kanagawa Cancer Center , Kanagawa 241-8515 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumiko","family":"Komine","sequence":"additional","affiliation":[{"name":"Riken Genesis Co., Ltd., Shinagawa-ku , Tokyo 141-0032 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Yuan","sequence":"additional","affiliation":[{"name":"Riken Genesis Co., Ltd., Shinagawa-ku , Tokyo 141-0032 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junko","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Riken Genesis Co., Ltd., Shinagawa-ku , Tokyo 141-0032 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seigo","family":"Katakura","sequence":"additional","affiliation":[{"name":"Department of Thoracic Oncology, Kanagawa Cancer Center , Kanagawa 241-8515 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuro","family":"Kondo","sequence":"additional","affiliation":[{"name":"Department of Thoracic Oncology, Kanagawa Cancer Center , Kanagawa 241-8515 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoyuki","family":"Yokose","sequence":"additional","affiliation":[{"name":"Department of Pathology, Kanagawa Cancer Center, Kanagawa Cancer Center , Kanagawa 241-8515 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruhiro","family":"Saito","sequence":"additional","affiliation":[{"name":"Department of Thoracic Oncology, Kanagawa Cancer Center , Kanagawa 241-8515 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2026,1,26]]},"reference":[{"key":"2026050701220598300_ref1","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1001\/jama.2014.3741","article-title":"Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugs","volume":"311","author":"Kris","year":"2014","journal-title":"JAMA"},{"key":"2026050701220598300_ref2","doi-asserted-by":"publisher","first-page":"e2347700","DOI":"10.1001\/jamanetworkopen.2023.47700","article-title":"Biomarker testing in patients with unresectable advanced or recurrent non-small cell lung cancer","volume":"6","author":"Sakamoto","year":"2023","journal-title":"JAMA Netw Open"},{"key":"2026050701220598300_ref3","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1111\/pin.13023","article-title":"Multiplex gene-panel testing for lung cancer patients","volume":"70","author":"Yatabe","year":"2020","journal-title":"Pathol Int"},{"key":"2026050701220598300_ref4","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1111\/1759-7714.13743","article-title":"Tissue surface area and tumor cell count affect the success rate of the Oncomine dx target test in the analysis of biopsy tissue samples","volume":"12","author":"Nemoto","year":"2021","journal-title":"Thorac Cancer"},{"key":"2026050701220598300_ref5","doi-asserted-by":"crossref","first-page":"391","DOI":"10.3390\/diagnostics11030391","article-title":"Suitability of bronchoscopic biopsy tissue samples for next-generation sequencing","volume":"11","author":"Murakami","year":"2021","journal-title":"Diagnostics (Basel)"},{"key":"2026050701220598300_ref6","doi-asserted-by":"publisher","first-page":"e7162","DOI":"10.1002\/cam4.7162","article-title":"Comparison between next-generation sequencing and multiplex polymerase chain reaction assays for nonsmall-cell lung cancer molecular diagnosis","volume":"13","author":"Murakami","year":"2024","journal-title":"Cancer Med"},{"key":"2026050701220598300_ref7","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.3390\/cancers7030859","article-title":"Analysis of pre-analytic factors affecting the success of clinical next-generation sequencing of solid organ malignancies","volume":"7","author":"Chen","year":"2015","journal-title":"Cancers (Basel)"},{"key":"2026050701220598300_ref8","doi-asserted-by":"publisher","first-page":"e22082","DOI":"10.1016\/j.heliyon.2023.e22082","article-title":"Enhancing tumour content and tumour cell count using microdissection contributes to higher detection rate of genetic mutations by next-generation sequencers","volume":"9","author":"Tamiya","year":"2023","journal-title":"Heliyon"},{"key":"2026050701220598300_ref9","doi-asserted-by":"crossref","first-page":"107190","DOI":"10.1016\/j.lungcan.2023.107190","article-title":"Clinical application of the AMOY 9-in-1 panel to lung cancer patients","volume":"179","author":"Kunimasa","year":"2023","journal-title":"Lung Cancer"},{"key":"2026050701220598300_ref10","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1111\/1759-7714.15382","article-title":"Suitability of frozen cell pellets from cytology specimens for the Amoy 9-in-1 assay in patients with non-small cell lung cancer","volume":"15","author":"Kodama","year":"2024","journal-title":"Thorac Cancer"},{"key":"2026050701220598300_ref11","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1378\/chest.126.3.959","article-title":"Endobronchial ultrasonography using a guide sheath increases the ability to diagnose peripheral pulmonary lesions endoscopically","volume":"126","author":"Kurimoto","year":"2004","journal-title":"Chest"},{"key":"2026050701220598300_ref12","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1097\/JTO.0b013e318267223a","article-title":"Prognostic impact of malignant pleural effusion at presentation in patients with metastatic non-small-cell lung cancer","volume":"7","author":"Morgensztern","year":"2012","journal-title":"J Thorac Oncol"},{"key":"2026050701220598300_ref13","doi-asserted-by":"crossref","first-page":"7","DOI":"10.25259\/Cytojournal_18_2021","article-title":"Adequacy of pleural fluid cytology for comprehensive molecular analysis of lung adenocarcinoma: experience of a large health-care system","volume":"19","author":"Dalvi","year":"2022","journal-title":"Cytoj"},{"key":"2026050701220598300_ref14","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s40291-024-00736-8","article-title":"Profiling cell-free DNA from malignant pleural effusion for oncogenic driver mutations in patients with treatment-naive stage IV adenocarcinoma: a multicenter prospective study","volume":"28","author":"Chang","year":"2024","journal-title":"Mol Diagn Ther"},{"key":"2026050701220598300_ref15","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.jmoldx.2017.10.007","article-title":"Comprehensive genomic profiling of malignant effusions in patients with metastatic lung adenocarcinoma","volume":"20","author":"Yang","year":"2018","journal-title":"J Mol Diagn"},{"key":"2026050701220598300_ref16","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1097\/JTO.0000000000000203","article-title":"Multiplexed molecular profiling of lung cancer using pleural effusion","volume":"9","author":"Akamatsu","year":"2014","journal-title":"J Thorac Oncol"},{"key":"2026050701220598300_ref17","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.lungcan.2019.05.018","article-title":"Comparative study of EGFR mutations detected in malignant pleural effusion, plasma and tumor tissue in patients with adenocarcinoma of the lung","volume":"135","author":"Wang","year":"2019","journal-title":"Lung Canc"}],"container-title":["Japanese Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jjco\/article-pdf\/56\/5\/605\/66577726\/hyag003.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jjco\/article-pdf\/56\/5\/605\/66577726\/hyag003.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T05:22:16Z","timestamp":1778131336000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jjco\/article\/56\/5\/605\/8441025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,26]]},"references-count":17,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,1,26]]},"published-print":{"date-parts":[[2026,5,7]]}},"URL":"https:\/\/doi.org\/10.1093\/jjco\/hyag003","relation":{},"ISSN":["1465-3621"],"issn-type":[{"value":"1465-3621","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,5]]},"published":{"date-parts":[[2026,1,26]]}}}